117 related articles for article (PubMed ID: 28986894)
1. Identification and Isolation of Cancer Stem Cells Using NANOG-EGFP Reporter System.
Buczek ME; Reeder SP; Regad T
Methods Mol Biol; 2018; 1692():139-148. PubMed ID: 28986894
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
3. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.
Jeter CR; Liu B; Liu X; Chen X; Liu C; Calhoun-Davis T; Repass J; Zaehres H; Shen JJ; Tang DG
Oncogene; 2011 Sep; 30(36):3833-45. PubMed ID: 21499299
[TBL] [Abstract][Full Text] [Related]
4. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
5. Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.
Costa CD; Justo AA; Kobayashi PE; Story MM; Palmieri C; Laufer Amorim R; Fonseca-Alves CE
Int J Biochem Cell Biol; 2019 Mar; 108():21-28. PubMed ID: 30633985
[TBL] [Abstract][Full Text] [Related]
6. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
[TBL] [Abstract][Full Text] [Related]
7. Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer.
Hu C; Xu L; Liang S; Zhang Z; Zhang Y; Zhang F
J Drug Target; 2016; 24(5):422-32. PubMed ID: 26339994
[TBL] [Abstract][Full Text] [Related]
8. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
9. [A Modified Lentivirus-Based Reporter for Magnetic Separation of Cancer Stem Cells].
Ivanova AE; Kravchenko DS; Chumakov SP
Mol Biol (Mosk); 2020; 54(1):95-102. PubMed ID: 32163393
[TBL] [Abstract][Full Text] [Related]
10. Berberis libanotica Ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells.
El-Merahbi R; Liu YN; Eid A; Daoud G; Hosry L; Monzer A; Mouhieddine TH; Hamade A; Najjar F; Abou-Kheir W
PLoS One; 2014; 9(11):e112453. PubMed ID: 25380390
[TBL] [Abstract][Full Text] [Related]
11. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
12. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L
Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540
[TBL] [Abstract][Full Text] [Related]
13. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
14. Implication of expression of Nanog in prostate cancer cells and their stem cells.
Gong C; Liao H; Guo F; Qin L; Qi J
J Huazhong Univ Sci Technolog Med Sci; 2012 Apr; 32(2):242-246. PubMed ID: 22528228
[TBL] [Abstract][Full Text] [Related]
15. Nanog, as a key cancer stem cell marker in tumor progression.
Vasefifar P; Motafakkerazad R; Maleki LA; Najafi S; Ghrobaninezhad F; Najafzadeh B; Alemohammad H; Amini M; Baghbanzadeh A; Baradaran B
Gene; 2022 Jun; 827():146448. PubMed ID: 35337852
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B
Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661
[TBL] [Abstract][Full Text] [Related]
17. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
18. How prostate-specific membrane antigen level may be correlated with stemness in prostate cancer stem cell-like cell populations?
Maria T; Panagiotis A; Marina C; Eleni K; Ioanna V; Georgia M; Ioannis P
J Cancer Res Ther; 2014; 10(1):133-41. PubMed ID: 24762500
[TBL] [Abstract][Full Text] [Related]
19. Insights into the
Zhang W; Sui Y; Ni J; Yang T
Int J Biol Sci; 2016; 12(11):1372-1381. PubMed ID: 27877089
[TBL] [Abstract][Full Text] [Related]
20. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells.
Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
